K34c

Cat. No. M30942

All AbMole products are for research use only, cannot be used for human consumption.

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.

K34c is a potent and selective α5β1 integrin antagonist. K34c can be used for glioblastoma research.

Molecular Weight	447.53
Formula	C26H29N3O4
CAS Number	939769-93-4
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.

Related Integrin Products
MORF-627 MORF-627 is a selective, orally active inhibitor for integrin αvβ6 with an IC50 of 9.2 nM (measuring by human serum ligand binding assay). MORF-627 inhibits αvβ6-mediated TGF-β1 activation with an IC50 of 2.63 nM, inhibits SMAD2/3 phosphorylation with an IC50 of 8.3 nM.
Volociximab Volociximab (M200) is a chimeric human/murine IgG4 antibody IIA1 targeting integrin α5β1 (EC50=0.2 nM). Volociximab has antiangiogenic and antitumor activities and inhibits the proliferation of human umbilical vein vascular endothelial cells (HUVECs).
GSK 3008348 hydrochloride GSK 3008348 hydrochloride is a small molecule integrin αvβ6 antagonist.
HSDVHK-NH2 HSDVHK-NH2 is an antagonist of the integrin αvβ3-vitronectin interaction, with an IC50 of 1.74 pg/mL (2.414 pM).
LDV LDV, a tripeptide, is a non-fluorescent analog of LDV-FITC.

Catalog